Stockholders' Equity (Tables)
|
3 Months Ended |
Apr. 30, 2026 |
| Equity [Abstract] |
|
| Schedule of Capital Units |
Common stock reserved for issuance as of April 30, 2026 and January 31, 2026 are presented as follows: | | | | | | | | | | | | | As of | | April 30, 2026 | | January 31, 2026 | | | | | | Stock options issued and outstanding | 37,455,860 | | | 39,283,485 | | | RSUs issued and outstanding | 18,806,310 | | | 9,311,201 | | | Shares of common stock available for future grants | 39,206,459 | | | 37,811,841 | | | Shares available for issuance under the 2025 Employee Stock Purchase Plan ("ESPP") | 7,491,747 | | | 5,000,000 | | | | | | | | | | | Total common stock reserved for issuance | 102,960,376 | | | 91,406,527 | |
|
| Schedule of Share-Based Payment Arrangement, Option, Activity |
The following table presents stock option activity for the three months ended April 30, 2026 (in thousands, except price per share, share and years data): | | | | | | | | | | | | | | | | | | | | | | | | | Number of Stock Options Outstanding | | Weighted-Average Exercise Price per Share | | Weighted- Average Remaining Contractual Life (Years) | | Aggregate Intrinsic Value | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Balance as of January 31, 2026 | 39,283,485 | | | $ | 13.91 | | | 5.7 | | $ | 55,743 | | | Granted | 1,010,099 | | | $ | 9.97 | | | | | | | Exercised | (2,451,289) | | | $ | 6.64 | | | | | $ | 16,981 | | | Cancelled/forfeited/expired | (386,435) | | | $ | 16.74 | | | | | | | Balance as of April 30, 2026 | 37,455,860 | | | $ | 14.25 | | | 5.7 | | $ | 145,849 | | | Vested and expected to vest as of April 30, 2026 | 37,455,860 | | | $ | 14.25 | | | 5.7 | | $ | 145,849 | | | Exercisable as of April 30, 2026 | 30,776,070 | | | $ | 13.32 | | | 5.3 | | $ | 135,182 | |
|
| Schedule of Share-Based Payment Arrangement, Restricted Stock Unit, Activity |
The following table presents the activity related to RSUs for the three months ended April 30, 2026: | | | | | | | | | | | | | Number of Shares Subject to RSUs | | Weighted-Average Grant Date Fair Value | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Unvested balance as of January 31, 2026 | 9,311,201 | | | $ | 22.23 | | | Granted | 10,915,113 | | | $ | 14.96 | | | Forfeited | (474,657) | | | $ | 22.71 | | | Vested | (945,347) | | | $ | 22.03 | | | Unvested and outstanding as of April 30, 2026 | 18,806,310 | | | $ | 18.01 | | | | | | | | | | | | | | | | | |
|
| Schedule of Stock-based Compensation |
Stock-based compensation is included in the following components of expenses within the condensed consolidated statements of operations (in thousands): | | | | | | | | | | | | | | | | | Three Months Ended April 30, | | | | 2026 | | 2025 | | | | | | Cost of revenue | $ | 1,720 | | | $ | 1,047 | | | | | | | Research and development | 10,964 | | | 6,898 | | | | | | | Sales and marketing | 8,255 | | | 3,595 | | | | | | | General and administrative | 16,373 | | | 5,720 | | | | | | Total stock-based compensation expense, net of amounts capitalized | $ | 37,312 | | | $ | 17,260 | | | | | | | Capitalized stock-based compensation | 1,074 | | | 570 | | | | | | Total stock-based compensation cost | $ | 38,386 | | | $ | 17,830 | | | | | |
|